Jump to content

King Edward Street Chapel, Macclesfield and Tryptophan: Difference between pages

From Wikipedia, the free encyclopedia
(Difference between pages)
Content deleted Content added
CohesionBot (talk | contribs)
m Repairing link to disambiguation page : Unitarian
 
 
Line 1: Line 1:
{{NatOrganicBox
{{Infobox religious building |building_name=King Edward Street Chapel, Macclesfield |image= | caption= | location=[[Macclesfield]], [[Cheshire]], [[England]] | map_type=| latitude= | longitude= |geo= |religious_affiliation=[[Unitarianism|Unitarian]] |district=Manchester |consecration_year= |status=Chapel |leadership= |website= |architect= |architecture_type=Chapel |architecture_style=[[Gothic Revival architecture|Gothic Revival]] |facade_direction= |year_completed=1690 |construction_cost= |capacity= |length={{convert|60|ft|m|0}} |width={{convert|20|ft|m|0}} |width_nave= |height_max= |dome_quantity= |dome_height_outer= |dome_height_inner= |dome_dia_outer= |dome_dia_inner= |minaret_quantity= |minaret_height= |spire_quantity= |spire_height= |materials=Red [[sandstone]]<br>Stone flagged-roof }}
| image= [[Image:L-tryptophan.svg|160px|Skeletal formula of tryptophan]][[Image:L-tryptophan-3D-sticks.png|160px|3D stick model of tryptophan molecule]]
'''King Edward Street Chapel, Macclesfield''' is in the town of [[Macclesfield]], [[Cheshire]], [[England]]. It is a Grade II* [[listed building]].<ref name="images">{{cite web |url=http://www.imagesofengland.org.uk/search/details.aspx?pid=1&id=391021 |title=Images of England: Unitarian Chapel, Macclesfield |accessdate=2007-10-22 |publisher=English Heritage}}</ref>
| name=(''S'')-2-Amino-3-(1H-indol-3-yl)-propionic acid
| PubChem = 6305
| CAS = 73-22-3
| SMILES = N[C@@H](Cc1c2ccccc2n([H])c1)C(O)=O
| C=11 | H=12 | N=2 | O=2
| mass=204.225 g/mol
}}


'''Tryptophan''' (abbreviated as '''Trp''' or '''W''')<ref>{{cite web | author=IUPAC-IUBMB Joint Commission on Biochemical Nomenclature | title=Nomenclature and Symbolism for Amino Acids and Peptides | work=Recommendations on Organic & Biochemical Nomenclature, Symbols & Terminology etc | url=http://www.chem.qmul.ac.uk/iupac/AminoAcid/ | accessdate=2007-05-17}}</ref> is one of the 20 [[List of standard amino acids|standard amino acids]], as well as an [[essential amino acid]] in the [[human]] diet. It is encoded in genetic code as the [[codon]] ''UGG''. Only the L-[[stereoisomer]] of tryptophan is used in [[Fibrous protein|structural]] or [[enzyme]] proteins, but the D-[[stereoisomer]] is occasionally found in naturally produced [[peptide]]s (for example, the marine venom [[peptide]] [[contryphan]]).<ref name="Pallaghy_1999">{{cite journal |author=Pallaghy PK, Melnikova AP, Jimenez EC, Olivera BM, Norton RS|title=Solution structure of contryphan-R, a naturally-occurring disulfide-bridged octapeptide containing D-tryptophan: comparison with protein loops|journal= Biochemistry |volume= 38 |issue= 35 |pages= 11553–9 |year= 1999 |pmid= 10471307 | doi = 10.1021/bi990685j}}</ref> The distinguishing structural characteristic of tryptophan is that it contains an [[indole]] functional group.
==History==


==Isolation==
The chapel was built in 1690, soon after the passing of the [[Act of Toleration 1689]]. Initially an independent chapel in the [[Trinity|Trinitarian]] tradition it became [[Unitarianism|Unitarian]] during the ministry of John Palmer between 1764 and 1780. Around 1800 the internal south gallery was removed. In the early 19th century a number of [[Gothic architecture|Gothic]] features were introduced to the interior. The old [[box pew]]s were replaced with bench pews in 1930. <ref name="richards">{{cite book | last =Richards | first =Raymond | title =Old Cheshire Churches | publisher =Batsford | date =1947 | location =London | pages =376&ndash;378}}</ref> It is still in use as a [[Unitarianism|Unitarian]] chapel.<ref>{{cite web |url=http://www.unitarian.org.uk/local_manchester.htm |title=The Unitarian Movement: Manchester District Association |accessdate=2007-10-23 |publisher=The Unitarian and Free Christian Churches }}</ref>
The isolation of tryptophan was first reported by [[Frederick Hopkins| Sir Frederick Hopkins]] in 1901 <ref name="pmid16992614">{{cite journal | author = Hopkins FG, Cole SW | title = A contribution to the chemistry of proteids: Part I. A preliminary study of a hitherto undescribed product of tryptic digestion | journal = J. Physiol. (Lond.) | volume = 27 | issue = 4-5 | pages = 418–28 | year = 1901 | pmid = 16992614 | doi = | issn = | url = http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1540554}}</ref> through hydrolysis of [[casein]]. From 600 [[gram]]s of crude casein one obtains 4-8 grams of tryptophan.<ref name="Cox_1943">{{cite journal | author = Cox GJ, King H | title = L-Tryptophane | journal = Organic Syntheses | volume = Collected Volume 2 | issue = | pages = 612–616 | year = 1943| doi = | issn = | url = http://www.orgsyn.org/orgsyn/pdfs/CV2P0612.pdf}}</ref>


== Biosynthesis and industrial production ==
==Structure==
Plants and [[microorganism]]s commonly synthesize tryptophan from [[shikimic acid]] or [[anthranilic acid|anthranilate]].<ref name="pmid7640526">{{cite journal | author = Radwanski ER, Last RL | title = Tryptophan biosynthesis and metabolism: biochemical and molecular genetics | journal = Plant Cell | volume = 7 | issue = 7 | pages = 921–34 | year = 1995 | pmid = 7640526 | doi = 10.1105/tpc.7.7.921 }}</ref> The latter condenses with [[phosphoribosylpyrophosphate]] (PRPP), generating [[pyrophosphate]] as a by-product. After ring opening of the ribose moiety and following reductive decarboxylation, indole-3-glycerinephosphate is produced, which in turn is transformed into [[indole]]. In the last step, tryptophan synthase catalyzes the formation of tryptophan from indole and the amino acid, [[serine]].
[[Image:Tryptophan biosynthesis.png|center|800px|test]]
The industrial production of tryptophan is also biosynthetic and is based on the fermentation of [[serine]] and [[indole]] using either wild-type or genetically modified ''[[E. coli]]''. The conversion is catalyzed by the enzyme [[tryptophan synthase]].<ref name="pmid12523387">{{cite journal | author = Ikeda M | title = Amino acid production processes | journal = Adv. Biochem. Eng. Biotechnol. | volume = 79 | issue = | pages = 1–35 | year = 2002 | pmid = 12523387 | doi = | issn = | url = http://www.springerlink.com/content/226q8plt36351kck}}</ref>


==Function==
The chapel lies behind other buildings and is approached by a narrow passageway from King Edward Street. It is built from local red [[sandstone]] and has a pair of external staircases leading to the east and west galleries. A lead downspout bears the date 1690. The chapel is {{convert|60|ft|m|0}} long and {{convert|20|ft|m|0}} wide.<ref name="richards"/>
[[Image:Tryptophan metabolism.png|thumb|365px|Metabolism of L-tryptophan into serotonin and melatonin (left) and niacin (right). Transformed functional groups after each chemical reaction are highlighted in red.]]
For many organisms (including humans), tryptophan is an [[essential amino acid]]. This means that it cannot be synthesized by the organism and therefore must be part of its diet. Amino acids, including tryptophan, act as building blocks in [[protein biosynthesis]]. In addition, tryptophan functions as a biochemical [[Precursor (chemistry)|precursor]] for the following compounds (see also figure to the right):
* [[Serotonin]] (a [[neurotransmitter]]), synthesized via [[tryptophan hydroxylase]].<ref name="pmid6132421">{{cite journal | author = Fernstrom JD | title = Role of precursor availability in control of monoamine biosynthesis in brain | journal = Physiol. Rev. | volume = 63 | issue = 2 | pages = 484–546 | year = 1983 | pmid = 6132421 | doi = | issn = | url = http://physrev.physiology.org/cgi/reprint/63/2/484}}</ref><ref name="pmid1704290">{{cite journal | author = Schaechter JD, Wurtman RJ | title = Serotonin release varies with brain tryptophan levels | journal = Brain Res. | volume = 532 | issue = 1-2 | pages = 203–10 | year = 1990 | pmid = 1704290 | doi = 10.1016/0006-8993(90)91761-5| url = http://wurtmanlab.mit.edu/publications/pdf/790.pdf}}</ref> Serotonin, in turn, can be converted to [[melatonin]] (a [[neurohormone]]), via [[N-Acetyltransferase|N-acetyltransferase]] and [[5-hydroxyindole-O-methyltransferase]] activities.<ref name="pmid4391290">{{cite journal | author = Wurtman RJ, Anton-Tay F | title = The mammalian pineal as a neuroendocrine transducer | journal = Recent Prog. Horm. Res. | volume = 25 | issue = | pages = 493–522 | year = 1969 | pmid = 4391290 | doi = | issn = | url = http://wurtmanlab.mit.edu/publications/pdf/104.pdf}}</ref>
* [[Niacin]] is synthesized from tryptophan via [[kynurenine]] and quinolinic acids as key biosynthetic intermediates.<ref name="pmid14284754">{{cite journal | author = Ikeda M, Tsuji H, Nakamura S, Ichiyama A, Nishizuka Y, Hayaishi O | title = Studies on the biosynthesis of nicotinamide adenine dinucleotide. II. A role of picolinic carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals | journal = J. Biol. Chem. | volume = 240 | issue = | pages = 1395–401 | year = 1965 | pmid = 14284754 | doi = | issn = | url = http://www.jbc.org/cgi/reprint/240/3/1395 }}</ref>


The disorder [[Fructose malabsorption|Fructose Malabsorption]] causes improper absorption of tryptophan in the intestine, reduced levels of tryptophan in the blood<ref>{{cite journal |author=Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D |title=Fructose malabsorption is associated with decreased plasma tryptophan |journal=Scand. J. Gastroenterol. |volume=36 |issue=4 |pages=367–71 |year=2001 |pmid=11336160 |doi=}}</ref> and depression.<ref>{{cite journal |author=Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D |title=Fructose malabsorption is associated with early signs of mental depression |journal=Eur. J. Med. Res. |volume=3 |issue=6 |pages=295–8 |year=1998 |pmid=9620891 |doi=}}</ref>
==Fittings and furniture==


In bacteria that synthesize tryptophan, high cellular levels of this amino acid activate a [[repressor]] protein, which binds to the [[trp operon]]. {{Fact|date=October 2007}} Binding of this repressor to the tryptophan operon prevents transcription of downstream DNA that codes for the enzymes involved in the biosynthesis of tryptophan. So high levels of tryptophan prevent tryptophan synthesis through a negative feedback loop and, when the cell's tryptophan levels are reduced, transcription from the trp operon resumes. The genetic organisation of the trp operon thus permits tightly regulated and rapid responses to changes in the cell's internal and external tryptophan levels.
A high two-decker [[pulpit]] is in the middle of the north side. Galleries are at the east and west ends. In the vestry are [[Oil painting|oil]] portraits of Thomas Culcheth, minister from 1717 to 1751, and his wife. There is an elaborately carved chair by William Leicester made in 1688. The communion table which was presented to the chapel in 1894 is also elaborately carved. The [[alabaster]] [[Baptism|christening]] bowl and its cover are dated 1842.<ref name="richards"/> In the east gallery is an organ dated 1846.<ref name="images"/> There are no memorials or gravestones. The registers date from 1713 and the treasurers' cash books from 1708. The chapel plate includes two silver cups dated 1728, three [[paten]]s dated 1841 and a late 17th century [[pewter]] baptismal bowl.<ref name="richards"/>


==Notes==
==Dietary sources==
Tryptophan is a routine constituent of most protein-based foods or dietary proteins. It is particularly plentiful in [[chocolate]], [[oat]]s, [[banana]]s, [[mango]]es, dried [[Date Palm|date]]s, [[milk]], [[yogurt]], [[cottage cheese]], [[red meat]], [[egg (food)|eggs]], [[fish]], [[poultry]], [[sesame]], [[chickpea]]s, [[sunflower seeds]], [[pumpkin seeds]], [[spirulina]], and [[peanut]]s.<ref name= Tryptophan_background >[http://www.vitamins-supplements.org/amino-acids/tryptophan.php Tryptophan background]</ref> It is also found in [[turkey (bird)|turkey]] at a level typical of poultry in general.<ref name = "USDA">{{cite web|title= USDA National Nutrient Database for Standard Reference, Release 20 | |publisher= United States Department of Agriculture | author = Joanne Holden, Nutrient Data Laboratory, Agricultural Research Service | url=http://www.ars.usda.gov/nutrientdata | accessdate = 2007-10-02}}</ref>
{{Reflist}}


{| class="wikitable sortable" style="background:white"
==External links==
|+ Tryptophan (Trp) Content of Various Foods<ref name = "USDA" /><ref name="Rambali">{{cite journal | author=Rambali B, Andel I van, Schenk E, Wolterink G, Werken G van de, Stevenson H, Vleeming W | title=[The contribution of cocoa additive to cigarette smoking addiction] | journal=RIVM | year=2002 | url=http://rivm.nl/bibliotheek/rapporten/650270002.pdf | format=PDF | issue=report 650270002/2002}}- The National Institute for Public Health and the Environment (Netherlands)</ref></center>
|-
!width="140 pt"|Food
!width="240 pt"|Protein <br>[g/100 g of food]
!width="200 pt"|Tryptophan <br>[g/100 g of food]
!width="180 pt"|Tryptophan/Protein [%]
|-
| egg, white, dried || <center>81.10</center> || <center>1.00</center> || <center>1.23</center>
|-
| spirulina, dried || <center>57.47</center> || <center>0.93</center> || <center>1.62</center>
|-
| cod, atlantic, dried || <center>62.82</center> || <center>0.70</center> || <center>1.11</center>
|-
| soybeans, raw || <center>36.49</center> || <center>0.59</center> || <center>1.62</center>
|-
| cheese, Parmesan || <center>37.90</center> || <center>0.56</center> || <center>1.47</center>
|-
| caribou || <center>29.77</center> || <center>0.46</center> || <center>1.55</center>
|-
| sesame seed || <center>17.00</center> || <center>0.37</center> || <center>2.17</center>
|-
| cheese, cheddar || <center>24.90</center> || <center>0.32</center> || <center>1.29</center>
|-
| sunflower seed || <center>17.20</center> || <center>0.30</center> || <center>1.74</center>
|-
| pork, chop || <center>19.27</center> || <center>0.25</center> || <center>1.27</center>
|-
| turkey || <center>21.89</center> || <center>0.24</center> || <center>1.11</center>
|-
| chicken || <center>20.85</center> || <center>0.24</center> || <center>1.14</center>
|-
| beef || <center>20.13</center> || <center>0.23</center> || <center>1.12</center>
|-
| salmon || <center>19.84</center> || <center>0.22</center> || <center>1.12</center>
|-
| lamb, chop || <center>18.33</center> || <center>0.21</center> || <center>1.17</center>
|-
| perch, Atlantic || <center>18.62</center> || <center>0.21</center> || <center>1.12</center>
|-
| egg || <center>12.58</center> || <center>0.17</center> || <center>1.33</center>
|-
| wheat flour, white || <center>10.33</center> || <center>0.13</center> || <center>1.23</center>
|-
| milk || <center>3.22</center> || <center>0.08</center> || <center>2.34</center>
|-
| rice, white || <center>7.13</center> || <center>0.08</center> || <center>1.16</center>
|-
| potatoes, russet || <center>2.14</center> || <center>0.02</center> || <center>0.84</center>
|-
| banana || <center>1.03</center> || <center>0.01</center> || <center>0.87</center>
|}


===Use as a dietary supplement===
*{{cite web |url=http://www.thornber.net/cheshire/htmlfiles/macclechap.html |title=Cheshire Antiquities: Macclesfield Chapels |accessdate= |last=Thornber |first=Craig |authorlink= |coauthors= |date= |year=2005 |month= |format= |work= |publisher= |pages= }}
For some time, tryptophan has been available in health food stores as a [[dietary supplement]], although it is common in dietary protein. Many people found tryptophan to be a safe and reasonably effective sleep aid, probably due to its ability to increase [[brain]] levels of [[serotonin]] (a calming [[neurotransmitter]] when present in moderate levels)<ref name="pmid6115400">{{cite journal | author = Wurtman RJ, Hefti F, Melamed E | title = Precursor control of neurotransmitter synthesis | journal = Pharmacol. Rev. | volume = 32 | issue = 4 | pages = 315–35 | year = 1980 | pmid = 6115400 | doi = | issn = | url = http://wurtmanlab.mit.edu/publications/pdf/466.pdf }}</ref> and/or [[melatonin]] (a sleep-inducing [[hormone]] secreted by the [[pineal gland]] in response to darkness or low light levels).<ref name="pmid5300432">{{cite journal | author = Wurtman RJ, Larin F, Axelrod J, Shein HM, Rosasco K | title = Formation of melatonin and 5-hydroxyindole acetic acid from 14C-tryptophan by rat pineal glands in organ culture | journal = Nature | volume = 217 | issue = 5132 | pages = 953–4 | year = 1968 | pmid = 5300432 | doi = 10.1038/217953a0 }}</ref><ref name="pmid16942634">{{cite journal | author = Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA | title = Tryptophan metabolism in the central nervous system: medical implications | journal = Expert reviews in molecular medicine | volume = 8 | issue = 20 | pages = 1–27 | year = 2006 | pmid = 16942634 | doi = 10.1017/S1462399406000068 }}</ref>
{{Churches in Cheshire}}


Clinical research has shown mixed results with respect to tryptophan's effectiveness as a sleep aid, especially in normal patients<ref name="pmid6764927">{{cite journal | author = Hartmann E | title = Effects of L-tryptophan on sleepiness and on sleep | journal = Journal of psychiatric research | volume = 17 | issue = 2 | pages = 107–13 | year = 1982 | pmid = 6764927 | doi = 10.1016/0022-3956(82)90012-7 }}</ref><ref name="pmid3090582">{{cite journal | author = Schneider-Helmert D, Spinweber CL | title = Evaluation of L-tryptophan for treatment of insomnia: a review | journal = Psychopharmacology (Berl.) | volume = 89 | issue = 1 | pages = 1–7 | year = 1986 | pmid = 3090582 | doi = 10.1007/BF00175180 }}</ref><ref name="pmid4097755">{{cite journal | author = Wyatt RJ, Engelman K, Kupfer DJ, Fram DH, Sjoerdsma A, Snyder F. | title = Effects of L-tryptophan (a natural sedative) on human sleep | journal = Lancet | volume = 1970 Oct 24,2 | issue = 7678 | pages = 842–6 | year = 1970 Oct 24| pmid = 4097755 | doi = | issn = 0140-6736}}</ref> and for a growing variety of other conditions typically associated with low serotonin levels or activity in the brain<ref>{{cite web|title=research summary of Dr. Richard Wurtman, MIT|url=http://web.mit.edu/bcs/people/wurtman.shtml|accessdate = 2007-08-12}}</ref> such as [[premenstrual dysphoric disorder]]
{{DEFAULTSORT:Macclesfield, King Edward Street Chapel}}
<ref name="pmid10023508">{{cite journal | author = Steinberg S, Annable L, Young SN, Liyanage N | title = A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria | journal = Biol. Psychiatry | volume = 45 | issue = 3 | pages = 313–20 | year = 1999 | pmid = 10023508 | doi = 10.1016/S0006-3223(98)00005-5 | issn = }}</ref> and [[seasonal affective disorder]].<ref name="pmid9114947">{{cite journal | author = Lam RW, Levitan RD, Tam EM, Yatham LN, Lamoureux S, Zis AP | title = L-tryptophan augmentation of light therapy in patients with seasonal affective disorder | journal = Canadian journal of psychiatry. Revue canadienne de psychiatrie | volume = 42 | issue = 3 | pages = 303–6 | year = 1997 | pmid = 9114947 | doi = | issn = | url = http://ww1.cpa-apc.org:8080/Publications/Archives/CJP/1997/April/apr97_bc1.htm }}</ref><ref name="Jepson_1999">{{cite journal |author=Jepson TL, Ernst ME, Kelly MW|title=Current perspectives on the management of seasonal affective disorder|journal= J Am Pharm Assoc (Wash) |volume= 39 |issue= 6 |pages= 822–9 |year= 1999 |pmid= 10609448|doi=10.1126/science.2237411.<br>|doi_brokendate=2008-06-25}}</ref> In particular, tryptophan has been showing considerable promise as an [[antidepressant]] alone,<ref name="pmid7156248">{{cite journal | author = Thomson J, Rankin H, Ashcroft GW, Yates CM, McQueen JK, Cummings SW | title = The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo | journal = Psychological medicine | volume = 12 | issue = 4 | pages = 741–51 | year = 1982 | pmid = 7156248 | doi = | issn = }}</ref> and as an "augmenter" of [[antidepressant]] drugs.<ref name="pmid7156248" /><ref name="pmid11022398">{{cite journal | author = Levitan RD, Shen JH, Jindal R, Driver HS, Kennedy SH, Shapiro CM | title = Preliminary randomized double-blind [[placebo]]-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects | journal = Journal of psychiatry & neuroscience : JPN | volume = 25 | issue = 4 | pages = 337–46 | year = 2000 | pmid = 11022398 | doi = | issn = | url = http://www.cma.ca/index.cfm/ci_id/12652/la_id/1.htm}}</ref> However, the reliability of these clinical trials has been questioned.<ref name="pmid10696120">{{cite journal | author = Meyers S | title = Use of neurotransmitter precursors for treatment of depression | journal = Alternative medicine review : a journal of clinical therapeutic | volume = 5 | issue = 1 | pages = 64–71 | year = 2000 | pmid = 10696120 | doi = | issn = | url = http://www.thorne.com/altmedrev/.fulltext/5/1/64.pdf }}</ref><ref name="pmid11869656">{{cite journal | author = Shaw K, Turner J, Del Mar C | title = Tryptophan and 5-hydroxytryptophan for depression | journal = Cochrane database of systematic reviews (Online) | volume = | issue = 1 | pages = CD003198 | year = 2002 | pmid = 11869656 | doi = 10.1002/14651858.CD003198 | issn = }}</ref>
[[Category:Chapels in England]]

[[Category:Grade II* listed churches]]
===Metabolites===
[[Category:Churches in Cheshire]]

[[Category:Grade II* listed buildings in Cheshire]]
[[5-Hydroxytryptophan]] (5-HTP), a metabolite of tryptophan, has been suggested as a treatment for [[epilepsy]]<ref name="Kostowski_1978">{{cite journal |author=Kostowski W, Bidzinski A, Hauptmann M, Malinowski JE, Jerlicz M, Dymecki J|title=Brain serotonin and epileptic seizures in mice: a pharmacological and biochemical study|journal= Pol J Pharmacol Pharm |volume= 30 |issue= 1 |pages= 41–7 |year= 1978 |pmid= 148040|doi=10.1126/science.2237411.<br>|doi_brokendate=2008-06-25}}</ref> and [[Clinical depression|depression]], although clinical trials are regarded inconclusive and lacking.<ref name="Turner_2006">{{cite journal |author=Turner EH, Loftis JM, Blackwell AD|title=Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan|journal= Pharmacol Ther |volume= 109 |issue= 3 |pages= 325–38 |year= 2006 |pmid= 16023217 | doi = 10.1016/j.pharmthera.2005.06.004}}</ref>
[[Category:1690 architecture]]

5-HTP readily crosses the [[blood-brain barrier]] and in addition is rapidly [[Decarboxylation|decarboxylated]] to [[serotonin]] (5-hydroxytryptamine or 5-HT)<ref name="Hardebo_1980">{{cite journal |author=Hardebo JE, Owman C|title=Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface|journal= Ann NeurolAnn Neurol |volume= 8 |issue= 1 |pages= 1–31 |year= 1980 |pmid= 6105837|doi=10.1002/ana.410080102}}</ref> and therefore may be useful for the treatment of depression. However serotonin has a relatively short half-life since it is rapidly metabolized by [[monoamine oxidase]], and therefore is likely to have limited efficacy. It is marketed in Europe for depression and other indications under the brand names Cincofarm and Tript-OH.

In the United States, 5-HTP does not require a prescription, as it is covered under the [[Dietary Supplement Health and Education Act|Dietary Supplement Act]]. However, since the quality of dietary supplements is not regulated by the [[FDA]], the quality of dietary and nutritional supplements tends to vary, and there is no guarantee that the label accurately depicts what the bottle contains.

=== Tryptophan supplements and EMS ===
Although currently available for purchase, in 1989 a large outbreak (1,500 cases of permanent disability including at least thirty-seven deaths) of a disabling [[autoimmune]] illness called [[eosinophilia-myalgia syndrome]] (EMS) was traced by some epidemiological studies<ref name="pmid2355442">{{cite journal | author = Slutsker L, Hoesly FC, Miller L, Williams LP, Watson JC, Fleming DW | title = Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer | journal = JAMA | volume = 264 | issue = 2 | pages = 213–7 | year = 1990 | pmid = 2355442| doi = 10.1001/jama.264.2.213| issn = }}</ref><ref name="pmid8496862">{{cite journal | author = Back EE, Henning KJ, Kallenbach LR, Brix KA, Gunn RA, Melius JM | title = Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York | journal = J. Rheumatol. | volume = 20 | issue = 4 | pages = 666–72 | year = 1993 | pmid = 8496862 | doi = | issn = }}</ref><ref name="pmid8895184">{{cite journal | author = Kilbourne EM, Philen RM, Kamb ML, Falk H | title = Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome | journal = The Journal of rheumatology. Supplement | volume = 46 | issue = | pages = 81–8; discussion 89–91 | year = 1996 | pmid = 8895184 | doi = | issn = }}</ref> to L-tryptophan supplied by a Japanese manufacturer, [[Showa Denko]] KK.<ref name= FDA_Tryptophan_Info >[http://vm.cfsan.fda.gov/~dms/ds-tryp1.html FDA Information Paper on L-tryptophan and 5-hydroxy-L-tryptophan]</ref> It was further hypothesized that one or more trace impurities produced during the manufacture of tryptophan may have been responsible for the EMS outbreak.<ref name="pmid2270484">{{cite journal | author = Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ | title = Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome | journal = Science | volume = 250 | issue = 4988 | pages = 1707–8 | year = 1990 | pmid = 2270484 | doi = 10.1126/science.2270484 | issn = }}</ref><ref name="pmid1544609">{{cite journal | author = Ito J, Hosaki Y, Torigoe Y, Sakimoto K | title = Identification of substances formed by decomposition of peak E substance in tryptophan | journal = Food Chem. Toxicol. | volume = 30 | issue = 1 | pages = 71–81 | year = 1992 | pmid = 1544609 | doi = 10.1016/0278-6915(92)90139-C | issn = }}</ref> It is important to note that the Showa Denko facility was the only one manufacturing L-Tryptohan starting in 1984 who started to [[genetically engineered]] bacteria to produce L-Tryptohan. As they started to increase the number of genes into their bacteria the corresponding increase in contamination levels followed.<ref>Smith, Jeffrey M. Genetic Roulette: The Documented Health Risks of Genetically Engineered Foods, Yes! Books, Fairfield, IA, 2007</ref> The most illness associated with the genetically engineered L-Tryptophan was a strain that produced five separate transgenes.<ref>A.N. Mayeno and G.J. Gleich, eds, "Eosinophilia-Myalgia Syndrome and Tryptophan Production: A Cautionary Tale." Trends Biotechnol 12 (1994): 346-352</ref> Furthermore the methodology used in the initial epidemiological studies has been criticized.<ref name="pmid8895181">{{cite journal | author = Shapiro S | title = Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique | journal = The Journal of rheumatology. Supplement | volume = 46 | issue = | pages = 44–58; discussion 58–9 | year = 1996 | pmid = 8895181 | doi = | issn = }}</ref><ref name="pmid8895182">{{cite journal | author = Horwitz RI, Daniels SR | title = Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome | journal = The Journal of rheumatology. Supplement | volume = 46 | issue = | pages = 60–72 | year = 1996 | pmid = 8895182 | doi = | issn = }}</ref> An alternative explanation for the 1989 EMS outbreak is that large doses of tryptophan produce [[metabolites]] which inhibit the normal degradation of [[histamine]] and excess histamine in turn has been proposed to cause EMS.<ref name="pmid16307217">{{cite journal | author = Smith MJ, Garrett RH | title = A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation | journal = Inflamm. Res. | volume = 54 | issue = 11 | pages = 435–50 | year = 2005 | pmid = 16307217 | doi = 10.1007/s00011-005-1380-7 | issn = }}</ref>

Most tryptophan was banned from sale in the US in 1991, and other countries followed suit. Tryptophan from one manufacturer, of six, continued to be sold for manufacture of baby formulas. A Rutgers Law Journal article observed, "Political pressures have played a role in the FDA's decision to ban L-tryptophan as well as its desire to increase its regulatory power over dietary supplements."<ref name="Beisler_2000">{{cite journal |author= Beisler JH|title=Dietary Supplements and Their Discontents: FDA Regulation and the Dietary Supplement Health and Education Act of 1994 (L-tryptophan Section)|journal= Rutgers Law Journal |volume= |issue= |pages= |year= 2000 |url = http://www.seedsofdeception.com/utility/showArticle/?objectID=263/|doi=10.1126/science.2237411.<br>|doi_brokendate=2008-06-25}}</ref>

At the time of the ban, the FDA did not know, or did not indicate, that EMS was caused by a contaminated batch,<ref name= FDA_Tryptophan_Recall >[http://www.fda.gov/bbs/topics/NEWS/NEW00064.html FDA Tryptophan Recall]</ref><ref>{{cite journal |author= Raphals P|title=Does medical mystery threaten biotech?|journal= Science |volume= 250 |issue= |pages= 4981 |year= 2000 |pmid = 2237411 | doi = 10.1126/science.2237411}}</ref> and yet, even when the contamination was discovered and the purification process fixed, the FDA maintained that L-tryptophan was unsafe. In February 2001, the FDA loosened the restrictions on marketing (though not on importation), but still expressed the following concern:
: ''"Based on the scientific evidence that is available at the present time, we cannot determine with certainty that the occurrence of EMS in susceptible persons consuming L-tryptophan supplements derives from the content of L-tryptophan, an impurity contained in the L-tryptophan, or a combination of the two in association with other, as yet unknown, external factors."''<ref name= FDA_Tryptophan_Info />

Since 2002, L-tryptophan has been sold in the U.S. in its original form. Several high-quality sources of L-tryptophan do exist, and are sold in many of the largest health food stores nationwide. Indeed, tryptophan has continued to be used in clinical and experimental studies employing human patients and subjects.

In recent years in the U.S., compounding [[pharmacy|pharmacies]] and some mail-order supplement retailers have begun selling tryptophan to the general public. Tryptophan has also remained on the market as a prescription drug (Tryptan), which some [[psychiatrist]]s continue to prescribe, particularly as an augmenting agent for people who are unresponsive to antidepressant drugs.{{Fact|date=February 2007}}

===Turkey meat and drowsiness===
One widely-held belief is that heavy consumption of [[turkey (bird)|turkey]] meat (as for example in a [[Thanksgiving]] or [[Christmas]] feast) results in drowsiness, which has been attributed to high levels of tryptophan contained in turkey.<ref name = "Helmenstine">{{cite web|title=About.com: Does Eating Turkey Make You Sleepy? | url=http://chemistry.about.com/od/holidaysseasons/a/tiredturkey.htm | accessdate = 2007-08-17}}</ref><ref name = "howstuffworks">{{cite web|title=Howstuffworks.com: Is there something in turkey that makes you sleepy? | url=http://home.howstuffworks.com/question519.htm | accessdate = 2007-08-17}}</ref><ref name = "McCue">{{cite web|title=Chemistry.org: Thanksgiving, Turkey, and Tryptophan | url=http://www.chemistry.org/portal/a/c/s/1/feature_ent.html?DOC=enthusiasts%5Cent_tryptophan.html | accessdate = 2007-08-17}}</ref> While turkey does contain high levels of tryptophan, the amount is comparable to that contained in most other meats.<ref name = "USDA" /> Furthermore, [[postprandial]] Thanksgiving [[sedation]] may have more to do with what is consumed along with the turkey, in particular [[carbohydrate]]s and [[alcohol]], rather than the turkey itself.

It has been demonstrated in both animal models<ref name="pmid5120086">{{cite journal | author = Fernstrom JD, Wurtman RJ | title = Brain serotonin content: increase following ingestion of carbohydrate diet | journal = Science | volume = 174 | issue = 13 | pages = 1023–5 | year = 1971 | pmid = 5120086 | doi = 10.1126/science.174.4013.1023 | issn = }}</ref> and in humans<ref name="pmid3279747">{{cite journal | author = Lyons PM, Truswell AS | title = Serotonin precursor influenced by type of carbohydrate meal in healthy adults | journal = Am. J. Clin. Nutr. | volume = 47 | issue = 3 | pages = 433–9 | year = 1988 | pmid = 3279747 | doi = | issn = | url = http://www.ajcn.org/cgi/reprint/47/3/433.pdf}}</ref><ref name="pmid12499331">{{cite journal | author = Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ | title = Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios | journal = Am. J. Clin. Nutr. | volume = 77 | issue = 1 | pages = 128–32 | year = 2003 | pmid = 12499331 | doi = | issn = | url = http://www.ajcn.org/cgi/content/abstract/77/1/128}}</ref><ref name="pmid17284739">{{cite journal | author = Afaghi A, O'Connor H, Chow CM | title = High-glycemic-index carbohydrate meals shorten sleep onset | journal = Am. J. Clin. Nutr. | volume = 85 | issue = 2 | pages = 426–30 | year = 2007 | pmid = 17284739 | doi = | issn = |url = http://www.ajcn.org/cgi/content/full/85/2/426}}</ref> that ingestion of a meal rich in carbohydrates triggers release of insulin. Insulin in turn stimulates the uptake of large neutral branched-chain amino acids (LNAA) but not tryptophan (trp) into muscle, increasing the ratio of trp to LNAA in the blood stream. The resulting increased ratio of tryptophan to large neutral amino acids in the blood reduces competition with other amino acids for the [[large neutral amino acid transporter]] protein for uptake of tryptophan across the [[blood-brain barrier]] into the [[central nervous system]] (CNS).<ref name="pmid1148286">{{cite journal | author = Pardridge WM, Oldendorf WH | title = Kinetic analysis of blood-brain barrier transport of amino acids | journal = Biochim. Biophys. Acta | volume = 401 | issue = 1 | pages = 128–36 | year = 1975 | pmid = 1148286 | doi = 10.1016/0005-2736(75)90347-8 | issn = }}</ref><ref name="pmid6538743">{{cite journal | author = Maher TJ, Glaeser BS, Wurtman RJ | title = Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake | journal = Am. J. Clin. Nutr. | volume = 39 | issue = 5 | pages = 722–9 | year = 1984 | pmid = 6538743 | doi = | issn = }}</ref> Once inside the CNS, tryptophan is converted into [[serotonin]] in the [[raphe nuclei]] by the normal enzymatic pathway.<ref name="pmid5120086" /><ref name="pmid12499331" /> The resultant serotonin is further metabolised into [[melatonin]] by the [[pineal gland]].<ref name="pmid4391290" /> Hence, these data suggest that "feast-induced drowsiness," and in particular, the common post-Christmas and Canadian post-Thanksgiving dinner drowsiness, may be the result of a heavy meal rich in carbohydrates which, via an indirect mechanism, increases the production of sleep-promoting melatonin in the brain.<ref name="pmid5120086" /><ref name="pmid3279747" /><ref name="pmid12499331" /><ref name="pmid17284739" />

== Fluorescence ==
The [[fluorescence]] of a folded protein is a mixture of the fluorescence from individual aromatic residues. Most of the intrinsic fluorescence emissions of a folded protein are due to excitation of tryptophan residues, with some emissions due to tyrosine and phenylalanine; but be aware that di-sulfide bonds also have appreciable absorption in this wavelength range. Typically, tryptophan has a wavelength of maximum absorption of 280 nm and an emission peak that is [[solvatochromic]], ranging from ca. 300 to 350 nm depending in the polarity of the local environment <ref>[http://dwb.unl.edu/Teacher/NSF/C08/C08Links/pps99.cryst.bbk.ac.uk/projects/gmocz/fluor.htm Intrinsic Fluorescence of Proteins and Peptides]</ref> Hence, protein fluorescence may be used as a diagnostic of the conformational state of a protein.<ref name="pmid11325713">{{cite journal | author = Vivian JT, Callis PR | title = Mechanisms of tryptophan fluorescence shifts in proteins | journal = Biophys. J. | volume = 80 | issue = 5 | pages = 2093–109 | year = 2001 | pmid = 11325713 | doi = | issn = | url = http://www.biophysj.org/cgi/content/abstract/80/5/2093 }}</ref> Furthermore, tryptophan fluorescence is strongly influenced by the proximity of other residues (''i.e.'', nearby ''protonated'' groups such as Asp or Glu can cause [[Quenching (fluorescence)|quenching]] of Trp fluorescence). Also, energy transfer between tryptophan and the other fluorescent amino acids is possible, which would affect the analysis, especially in cases where the Förster acidic approach is taken. In addition, tryptophan is a relatively rare amino acid; many proteins contain only one or a few tryptophan residues. Therefore, tryptophan fluorescence can be a very sensitive measurement of the conformational state of individual tryptophan residues. The advantage compared to extrinsic probes is that the protein itself is not changed. The use of intrinsic fluorescence for the study of protein conformation is in practice limited to cases with few (or perhaps only one) tryptophan residues, since each experiences a different local environment, which gives rise to different emission spectra.

== See also ==
* [[Serotonin]]
* [[5-HTP]]
* [[Tryptamine]]

==References==
{{reflist|2}}

== External links ==
* {{cite web | url = http://www.genome.jp/dbget-bin/www_bget?path:hsa00380 | title = KEGG PATHWAY: Tryptophan metabolism - Homo sapiens | author = | authorlink = | coauthors = | date = 2006-08-23 | format = | work = | publisher = KEGG: Kyoto Encyclopedia of Genes and Genomes | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-04-20}}
* {{cite web | url = http://www.chem.qmul.ac.uk/iubmb/enzyme/reaction/AminoAcid/TrpCat1.html | title = Tryptophan Catabolism (early stages) | author = G.P. Moss | authorlink = | coauthors = | date = | format = | work = | publisher = Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB) | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-04-20}}
* {{cite web | url = http://www.chem.qmul.ac.uk/iubmb/enzyme/reaction/AminoAcid/TrpCat2.html | title = Tryptophan Catabolism (later stages) | author = G.P. Moss | authorlink = | coauthors = | date = | format = | work = | publisher = Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB) | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-04-20}}
* {{cite web | url = http://www.snopes.com/food/ingredient/turkey.asp | title = Turkey Causes Sleepiness | author = B Mikkelson, DP Mikkelson | authorlink = | coauthors = | date = 2007-11-22 | format = | work = Urban Legends Reference Pages | publisher = Snopes.com | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-04-20}}
* {{cite journal | author = Wood RM, Rilling JK, Sanfey AG, Bhagwagar Z, Rogers RD | title = Effects of tryptophan depletion on the performance of an iterated Prisoner's Dilemma game in healthy adults | journal = Neuropsychopharmacology | volume = 31 | issue = 5 | pages = 1075–84 | year = 2006 | pmid = 16407905 | doi = 10.1038/sj.npp.1300932 | url = | issn = }}

{{AminoAcids}}
{{Tryptamines}}

[[Category:Proteinogenic amino acids]]
[[Category:Glucogenic amino acids]]
[[Category:Ketogenic amino acids]]
[[Category:Aromatic amino acids]]
[[Category:Essential amino acids]]
[[Category:Tryptamines]]
[[Category:Natural tryptamine alkaloids]]
[[Category:Dietary supplements]]

[[bn:ট্রিপ্টোফ্যান]]
[[ca:Triptòfan]]
[[cs:Tryptofan]]
[[da:Tryptofan]]
[[de:Tryptophan]]
[[es:Triptófano]]
[[eo:Triptofano]]
[[fr:Tryptophane]]
[[ko:트립토판]]
[[hr:Triptofan]]
[[id:Triptofan]]
[[it:Triptofano]]
[[he:טריפטופן]]
[[lv:Triptofāns]]
[[lb:Tryptophan]]
[[lt:Triptofanas]]
[[nl:Tryptofaan]]
[[ja:トリプトファン]]
[[no:Tryptofan]]
[[oc:Triptofan]]
[[pl:Tryptofan]]
[[pt:Triptófano]]
[[ro:Triptofan]]
[[ru:Триптофан]]
[[sk:Tryptofán]]
[[fi:Tryptofaani]]
[[sv:Tryptofan]]
[[tr:Triptofan]]
[[uk:Триптофан]]
[[zh:色氨酸]]

Revision as of 03:59, 13 October 2008

Template:NatOrganicBox

Tryptophan (abbreviated as Trp or W)[1] is one of the 20 standard amino acids, as well as an essential amino acid in the human diet. It is encoded in genetic code as the codon UGG. Only the L-stereoisomer of tryptophan is used in structural or enzyme proteins, but the D-stereoisomer is occasionally found in naturally produced peptides (for example, the marine venom peptide contryphan).[2] The distinguishing structural characteristic of tryptophan is that it contains an indole functional group.

Isolation

The isolation of tryptophan was first reported by Sir Frederick Hopkins in 1901 [3] through hydrolysis of casein. From 600 grams of crude casein one obtains 4-8 grams of tryptophan.[4]

Biosynthesis and industrial production

Plants and microorganisms commonly synthesize tryptophan from shikimic acid or anthranilate.[5] The latter condenses with phosphoribosylpyrophosphate (PRPP), generating pyrophosphate as a by-product. After ring opening of the ribose moiety and following reductive decarboxylation, indole-3-glycerinephosphate is produced, which in turn is transformed into indole. In the last step, tryptophan synthase catalyzes the formation of tryptophan from indole and the amino acid, serine.

test
test

The industrial production of tryptophan is also biosynthetic and is based on the fermentation of serine and indole using either wild-type or genetically modified E. coli. The conversion is catalyzed by the enzyme tryptophan synthase.[6]

Function

Metabolism of L-tryptophan into serotonin and melatonin (left) and niacin (right). Transformed functional groups after each chemical reaction are highlighted in red.

For many organisms (including humans), tryptophan is an essential amino acid. This means that it cannot be synthesized by the organism and therefore must be part of its diet. Amino acids, including tryptophan, act as building blocks in protein biosynthesis. In addition, tryptophan functions as a biochemical precursor for the following compounds (see also figure to the right):

The disorder Fructose Malabsorption causes improper absorption of tryptophan in the intestine, reduced levels of tryptophan in the blood[11] and depression.[12]

In bacteria that synthesize tryptophan, high cellular levels of this amino acid activate a repressor protein, which binds to the trp operon. [citation needed] Binding of this repressor to the tryptophan operon prevents transcription of downstream DNA that codes for the enzymes involved in the biosynthesis of tryptophan. So high levels of tryptophan prevent tryptophan synthesis through a negative feedback loop and, when the cell's tryptophan levels are reduced, transcription from the trp operon resumes. The genetic organisation of the trp operon thus permits tightly regulated and rapid responses to changes in the cell's internal and external tryptophan levels.

Dietary sources

Tryptophan is a routine constituent of most protein-based foods or dietary proteins. It is particularly plentiful in chocolate, oats, bananas, mangoes, dried dates, milk, yogurt, cottage cheese, red meat, eggs, fish, poultry, sesame, chickpeas, sunflower seeds, pumpkin seeds, spirulina, and peanuts.[13] It is also found in turkey at a level typical of poultry in general.[14]

Tryptophan (Trp) Content of Various Foods[14][15]
Food Protein
[g/100 g of food]
Tryptophan
[g/100 g of food]
Tryptophan/Protein [%]
egg, white, dried
81.10
1.00
1.23
spirulina, dried
57.47
0.93
1.62
cod, atlantic, dried
62.82
0.70
1.11
soybeans, raw
36.49
0.59
1.62
cheese, Parmesan
37.90
0.56
1.47
caribou
29.77
0.46
1.55
sesame seed
17.00
0.37
2.17
cheese, cheddar
24.90
0.32
1.29
sunflower seed
17.20
0.30
1.74
pork, chop
19.27
0.25
1.27
turkey
21.89
0.24
1.11
chicken
20.85
0.24
1.14
beef
20.13
0.23
1.12
salmon
19.84
0.22
1.12
lamb, chop
18.33
0.21
1.17
perch, Atlantic
18.62
0.21
1.12
egg
12.58
0.17
1.33
wheat flour, white
10.33
0.13
1.23
milk
3.22
0.08
2.34
rice, white
7.13
0.08
1.16
potatoes, russet
2.14
0.02
0.84
banana
1.03
0.01
0.87

Use as a dietary supplement

For some time, tryptophan has been available in health food stores as a dietary supplement, although it is common in dietary protein. Many people found tryptophan to be a safe and reasonably effective sleep aid, probably due to its ability to increase brain levels of serotonin (a calming neurotransmitter when present in moderate levels)[16] and/or melatonin (a sleep-inducing hormone secreted by the pineal gland in response to darkness or low light levels).[17][18]

Clinical research has shown mixed results with respect to tryptophan's effectiveness as a sleep aid, especially in normal patients[19][20][21] and for a growing variety of other conditions typically associated with low serotonin levels or activity in the brain[22] such as premenstrual dysphoric disorder [23] and seasonal affective disorder.[24][25] In particular, tryptophan has been showing considerable promise as an antidepressant alone,[26] and as an "augmenter" of antidepressant drugs.[26][27] However, the reliability of these clinical trials has been questioned.[28][29]

Metabolites

5-Hydroxytryptophan (5-HTP), a metabolite of tryptophan, has been suggested as a treatment for epilepsy[30] and depression, although clinical trials are regarded inconclusive and lacking.[31]

5-HTP readily crosses the blood-brain barrier and in addition is rapidly decarboxylated to serotonin (5-hydroxytryptamine or 5-HT)[32] and therefore may be useful for the treatment of depression. However serotonin has a relatively short half-life since it is rapidly metabolized by monoamine oxidase, and therefore is likely to have limited efficacy. It is marketed in Europe for depression and other indications under the brand names Cincofarm and Tript-OH.

In the United States, 5-HTP does not require a prescription, as it is covered under the Dietary Supplement Act. However, since the quality of dietary supplements is not regulated by the FDA, the quality of dietary and nutritional supplements tends to vary, and there is no guarantee that the label accurately depicts what the bottle contains.

Tryptophan supplements and EMS

Although currently available for purchase, in 1989 a large outbreak (1,500 cases of permanent disability including at least thirty-seven deaths) of a disabling autoimmune illness called eosinophilia-myalgia syndrome (EMS) was traced by some epidemiological studies[33][34][35] to L-tryptophan supplied by a Japanese manufacturer, Showa Denko KK.[36] It was further hypothesized that one or more trace impurities produced during the manufacture of tryptophan may have been responsible for the EMS outbreak.[37][38] It is important to note that the Showa Denko facility was the only one manufacturing L-Tryptohan starting in 1984 who started to genetically engineered bacteria to produce L-Tryptohan. As they started to increase the number of genes into their bacteria the corresponding increase in contamination levels followed.[39] The most illness associated with the genetically engineered L-Tryptophan was a strain that produced five separate transgenes.[40] Furthermore the methodology used in the initial epidemiological studies has been criticized.[41][42] An alternative explanation for the 1989 EMS outbreak is that large doses of tryptophan produce metabolites which inhibit the normal degradation of histamine and excess histamine in turn has been proposed to cause EMS.[43]

Most tryptophan was banned from sale in the US in 1991, and other countries followed suit. Tryptophan from one manufacturer, of six, continued to be sold for manufacture of baby formulas. A Rutgers Law Journal article observed, "Political pressures have played a role in the FDA's decision to ban L-tryptophan as well as its desire to increase its regulatory power over dietary supplements."[44]

At the time of the ban, the FDA did not know, or did not indicate, that EMS was caused by a contaminated batch,[45][46] and yet, even when the contamination was discovered and the purification process fixed, the FDA maintained that L-tryptophan was unsafe. In February 2001, the FDA loosened the restrictions on marketing (though not on importation), but still expressed the following concern:

"Based on the scientific evidence that is available at the present time, we cannot determine with certainty that the occurrence of EMS in susceptible persons consuming L-tryptophan supplements derives from the content of L-tryptophan, an impurity contained in the L-tryptophan, or a combination of the two in association with other, as yet unknown, external factors."[36]

Since 2002, L-tryptophan has been sold in the U.S. in its original form. Several high-quality sources of L-tryptophan do exist, and are sold in many of the largest health food stores nationwide. Indeed, tryptophan has continued to be used in clinical and experimental studies employing human patients and subjects.

In recent years in the U.S., compounding pharmacies and some mail-order supplement retailers have begun selling tryptophan to the general public. Tryptophan has also remained on the market as a prescription drug (Tryptan), which some psychiatrists continue to prescribe, particularly as an augmenting agent for people who are unresponsive to antidepressant drugs.[citation needed]

Turkey meat and drowsiness

One widely-held belief is that heavy consumption of turkey meat (as for example in a Thanksgiving or Christmas feast) results in drowsiness, which has been attributed to high levels of tryptophan contained in turkey.[47][48][49] While turkey does contain high levels of tryptophan, the amount is comparable to that contained in most other meats.[14] Furthermore, postprandial Thanksgiving sedation may have more to do with what is consumed along with the turkey, in particular carbohydrates and alcohol, rather than the turkey itself.

It has been demonstrated in both animal models[50] and in humans[51][52][53] that ingestion of a meal rich in carbohydrates triggers release of insulin. Insulin in turn stimulates the uptake of large neutral branched-chain amino acids (LNAA) but not tryptophan (trp) into muscle, increasing the ratio of trp to LNAA in the blood stream. The resulting increased ratio of tryptophan to large neutral amino acids in the blood reduces competition with other amino acids for the large neutral amino acid transporter protein for uptake of tryptophan across the blood-brain barrier into the central nervous system (CNS).[54][55] Once inside the CNS, tryptophan is converted into serotonin in the raphe nuclei by the normal enzymatic pathway.[50][52] The resultant serotonin is further metabolised into melatonin by the pineal gland.[9] Hence, these data suggest that "feast-induced drowsiness," and in particular, the common post-Christmas and Canadian post-Thanksgiving dinner drowsiness, may be the result of a heavy meal rich in carbohydrates which, via an indirect mechanism, increases the production of sleep-promoting melatonin in the brain.[50][51][52][53]

Fluorescence

The fluorescence of a folded protein is a mixture of the fluorescence from individual aromatic residues. Most of the intrinsic fluorescence emissions of a folded protein are due to excitation of tryptophan residues, with some emissions due to tyrosine and phenylalanine; but be aware that di-sulfide bonds also have appreciable absorption in this wavelength range. Typically, tryptophan has a wavelength of maximum absorption of 280 nm and an emission peak that is solvatochromic, ranging from ca. 300 to 350 nm depending in the polarity of the local environment [56] Hence, protein fluorescence may be used as a diagnostic of the conformational state of a protein.[57] Furthermore, tryptophan fluorescence is strongly influenced by the proximity of other residues (i.e., nearby protonated groups such as Asp or Glu can cause quenching of Trp fluorescence). Also, energy transfer between tryptophan and the other fluorescent amino acids is possible, which would affect the analysis, especially in cases where the Förster acidic approach is taken. In addition, tryptophan is a relatively rare amino acid; many proteins contain only one or a few tryptophan residues. Therefore, tryptophan fluorescence can be a very sensitive measurement of the conformational state of individual tryptophan residues. The advantage compared to extrinsic probes is that the protein itself is not changed. The use of intrinsic fluorescence for the study of protein conformation is in practice limited to cases with few (or perhaps only one) tryptophan residues, since each experiences a different local environment, which gives rise to different emission spectra.

See also

References

  1. ^ IUPAC-IUBMB Joint Commission on Biochemical Nomenclature. "Nomenclature and Symbolism for Amino Acids and Peptides". Recommendations on Organic & Biochemical Nomenclature, Symbols & Terminology etc. Retrieved 2007-05-17.
  2. ^ Pallaghy PK, Melnikova AP, Jimenez EC, Olivera BM, Norton RS (1999). "Solution structure of contryphan-R, a naturally-occurring disulfide-bridged octapeptide containing D-tryptophan: comparison with protein loops". Biochemistry. 38 (35): 11553–9. doi:10.1021/bi990685j. PMID 10471307.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Hopkins FG, Cole SW (1901). "A contribution to the chemistry of proteids: Part I. A preliminary study of a hitherto undescribed product of tryptic digestion". J. Physiol. (Lond.). 27 (4–5): 418–28. PMID 16992614.
  4. ^ Cox GJ, King H (1943). "L-Tryptophane" (PDF). Organic Syntheses. Collected Volume 2: 612–616.
  5. ^ Radwanski ER, Last RL (1995). "Tryptophan biosynthesis and metabolism: biochemical and molecular genetics". Plant Cell. 7 (7): 921–34. doi:10.1105/tpc.7.7.921. PMID 7640526.
  6. ^ Ikeda M (2002). "Amino acid production processes". Adv. Biochem. Eng. Biotechnol. 79: 1–35. PMID 12523387.
  7. ^ Fernstrom JD (1983). "Role of precursor availability in control of monoamine biosynthesis in brain". Physiol. Rev. 63 (2): 484–546. PMID 6132421.
  8. ^ Schaechter JD, Wurtman RJ (1990). "Serotonin release varies with brain tryptophan levels" (PDF). Brain Res. 532 (1–2): 203–10. doi:10.1016/0006-8993(90)91761-5. PMID 1704290.
  9. ^ a b Wurtman RJ, Anton-Tay F (1969). "The mammalian pineal as a neuroendocrine transducer" (PDF). Recent Prog. Horm. Res. 25: 493–522. PMID 4391290.
  10. ^ Ikeda M, Tsuji H, Nakamura S, Ichiyama A, Nishizuka Y, Hayaishi O (1965). "Studies on the biosynthesis of nicotinamide adenine dinucleotide. II. A role of picolinic carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals". J. Biol. Chem. 240: 1395–401. PMID 14284754.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  11. ^ Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D (2001). "Fructose malabsorption is associated with decreased plasma tryptophan". Scand. J. Gastroenterol. 36 (4): 367–71. PMID 11336160.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  12. ^ Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D (1998). "Fructose malabsorption is associated with early signs of mental depression". Eur. J. Med. Res. 3 (6): 295–8. PMID 9620891.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  13. ^ Tryptophan background
  14. ^ a b c Joanne Holden, Nutrient Data Laboratory, Agricultural Research Service. "USDA National Nutrient Database for Standard Reference, Release 20". United States Department of Agriculture. Retrieved 2007-10-02. {{cite web}}: Cite has empty unknown parameter: |1= (help)CS1 maint: multiple names: authors list (link)
  15. ^ Rambali B, Andel I van, Schenk E, Wolterink G, Werken G van de, Stevenson H, Vleeming W (2002). "[The contribution of cocoa additive to cigarette smoking addiction]" (PDF). RIVM (report 650270002/2002).{{cite journal}}: CS1 maint: multiple names: authors list (link)- The National Institute for Public Health and the Environment (Netherlands)
  16. ^ Wurtman RJ, Hefti F, Melamed E (1980). "Precursor control of neurotransmitter synthesis" (PDF). Pharmacol. Rev. 32 (4): 315–35. PMID 6115400.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  17. ^ Wurtman RJ, Larin F, Axelrod J, Shein HM, Rosasco K (1968). "Formation of melatonin and 5-hydroxyindole acetic acid from 14C-tryptophan by rat pineal glands in organ culture". Nature. 217 (5132): 953–4. doi:10.1038/217953a0. PMID 5300432.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. ^ Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA (2006). "Tryptophan metabolism in the central nervous system: medical implications". Expert reviews in molecular medicine. 8 (20): 1–27. doi:10.1017/S1462399406000068. PMID 16942634.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  19. ^ Hartmann E (1982). "Effects of L-tryptophan on sleepiness and on sleep". Journal of psychiatric research. 17 (2): 107–13. doi:10.1016/0022-3956(82)90012-7. PMID 6764927.
  20. ^ Schneider-Helmert D, Spinweber CL (1986). "Evaluation of L-tryptophan for treatment of insomnia: a review". Psychopharmacology (Berl.). 89 (1): 1–7. doi:10.1007/BF00175180. PMID 3090582.
  21. ^ Wyatt RJ, Engelman K, Kupfer DJ, Fram DH, Sjoerdsma A, Snyder F. (1970 Oct 24). "Effects of L-tryptophan (a natural sedative) on human sleep". Lancet. 1970 Oct 24, 2 (7678): 842–6. ISSN 0140-6736. PMID 4097755. {{cite journal}}: Check date values in: |year= (help)CS1 maint: multiple names: authors list (link)
  22. ^ "research summary of Dr. Richard Wurtman, MIT". Retrieved 2007-08-12.
  23. ^ Steinberg S, Annable L, Young SN, Liyanage N (1999). "A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria". Biol. Psychiatry. 45 (3): 313–20. doi:10.1016/S0006-3223(98)00005-5. PMID 10023508.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  24. ^ Lam RW, Levitan RD, Tam EM, Yatham LN, Lamoureux S, Zis AP (1997). "L-tryptophan augmentation of light therapy in patients with seasonal affective disorder". Canadian journal of psychiatry. Revue canadienne de psychiatrie. 42 (3): 303–6. PMID 9114947.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  25. ^ Jepson TL, Ernst ME, Kelly MW (1999). "Current perspectives on the management of seasonal affective disorder". J Am Pharm Assoc (Wash). 39 (6): 822–9. doi:10.1126/science.2237411.<br>. PMID 10609448. {{cite journal}}: Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help)CS1 maint: multiple names: authors list (link)
  26. ^ a b Thomson J, Rankin H, Ashcroft GW, Yates CM, McQueen JK, Cummings SW (1982). "The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo". Psychological medicine. 12 (4): 741–51. PMID 7156248.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  27. ^ Levitan RD, Shen JH, Jindal R, Driver HS, Kennedy SH, Shapiro CM (2000). "Preliminary randomized double-blind [[placebo]]-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects". Journal of psychiatry & neuroscience : JPN. 25 (4): 337–46. PMID 11022398. {{cite journal}}: URL–wikilink conflict (help)CS1 maint: multiple names: authors list (link)
  28. ^ Meyers S (2000). "Use of neurotransmitter precursors for treatment of depression" (PDF). Alternative medicine review : a journal of clinical therapeutic. 5 (1): 64–71. PMID 10696120.
  29. ^ Shaw K, Turner J, Del Mar C (2002). "Tryptophan and 5-hydroxytryptophan for depression". Cochrane database of systematic reviews (Online) (1): CD003198. doi:10.1002/14651858.CD003198. PMID 11869656.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  30. ^ Kostowski W, Bidzinski A, Hauptmann M, Malinowski JE, Jerlicz M, Dymecki J (1978). "Brain serotonin and epileptic seizures in mice: a pharmacological and biochemical study". Pol J Pharmacol Pharm. 30 (1): 41–7. doi:10.1126/science.2237411.<br>. PMID 148040. {{cite journal}}: Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help)CS1 maint: multiple names: authors list (link)
  31. ^ Turner EH, Loftis JM, Blackwell AD (2006). "Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan". Pharmacol Ther. 109 (3): 325–38. doi:10.1016/j.pharmthera.2005.06.004. PMID 16023217.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  32. ^ Hardebo JE, Owman C (1980). "Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface". Ann NeurolAnn Neurol. 8 (1): 1–31. doi:10.1002/ana.410080102. PMID 6105837.
  33. ^ Slutsker L, Hoesly FC, Miller L, Williams LP, Watson JC, Fleming DW (1990). "Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer". JAMA. 264 (2): 213–7. doi:10.1001/jama.264.2.213. PMID 2355442.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  34. ^ Back EE, Henning KJ, Kallenbach LR, Brix KA, Gunn RA, Melius JM (1993). "Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York". J. Rheumatol. 20 (4): 666–72. PMID 8496862.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  35. ^ Kilbourne EM, Philen RM, Kamb ML, Falk H (1996). "Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome". The Journal of rheumatology. Supplement. 46: 81–8, discussion 89–91. PMID 8895184.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  36. ^ a b FDA Information Paper on L-tryptophan and 5-hydroxy-L-tryptophan
  37. ^ Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ (1990). "Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome". Science. 250 (4988): 1707–8. doi:10.1126/science.2270484. PMID 2270484.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  38. ^ Ito J, Hosaki Y, Torigoe Y, Sakimoto K (1992). "Identification of substances formed by decomposition of peak E substance in tryptophan". Food Chem. Toxicol. 30 (1): 71–81. doi:10.1016/0278-6915(92)90139-C. PMID 1544609.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  39. ^ Smith, Jeffrey M. Genetic Roulette: The Documented Health Risks of Genetically Engineered Foods, Yes! Books, Fairfield, IA, 2007
  40. ^ A.N. Mayeno and G.J. Gleich, eds, "Eosinophilia-Myalgia Syndrome and Tryptophan Production: A Cautionary Tale." Trends Biotechnol 12 (1994): 346-352
  41. ^ Shapiro S (1996). "Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique". The Journal of rheumatology. Supplement. 46: 44–58, discussion 58–9. PMID 8895181.
  42. ^ Horwitz RI, Daniels SR (1996). "Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome". The Journal of rheumatology. Supplement. 46: 60–72. PMID 8895182.
  43. ^ Smith MJ, Garrett RH (2005). "A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation". Inflamm. Res. 54 (11): 435–50. doi:10.1007/s00011-005-1380-7. PMID 16307217.
  44. ^ Beisler JH (2000). "Dietary Supplements and Their Discontents: FDA Regulation and the Dietary Supplement Health and Education Act of 1994 (L-tryptophan Section)". Rutgers Law Journal. doi:10.1126/science.2237411.<br>. {{cite journal}}: Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help)
  45. ^ FDA Tryptophan Recall
  46. ^ Raphals P (2000). "Does medical mystery threaten biotech?". Science. 250: 4981. doi:10.1126/science.2237411. PMID 2237411.
  47. ^ "About.com: Does Eating Turkey Make You Sleepy?". Retrieved 2007-08-17.
  48. ^ "Howstuffworks.com: Is there something in turkey that makes you sleepy?". Retrieved 2007-08-17.
  49. ^ "Chemistry.org: Thanksgiving, Turkey, and Tryptophan". Retrieved 2007-08-17.
  50. ^ a b c Fernstrom JD, Wurtman RJ (1971). "Brain serotonin content: increase following ingestion of carbohydrate diet". Science. 174 (13): 1023–5. doi:10.1126/science.174.4013.1023. PMID 5120086.
  51. ^ a b Lyons PM, Truswell AS (1988). "Serotonin precursor influenced by type of carbohydrate meal in healthy adults" (PDF). Am. J. Clin. Nutr. 47 (3): 433–9. PMID 3279747.
  52. ^ a b c Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ (2003). "Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios". Am. J. Clin. Nutr. 77 (1): 128–32. PMID 12499331.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  53. ^ a b Afaghi A, O'Connor H, Chow CM (2007). "High-glycemic-index carbohydrate meals shorten sleep onset". Am. J. Clin. Nutr. 85 (2): 426–30. PMID 17284739.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  54. ^ Pardridge WM, Oldendorf WH (1975). "Kinetic analysis of blood-brain barrier transport of amino acids". Biochim. Biophys. Acta. 401 (1): 128–36. doi:10.1016/0005-2736(75)90347-8. PMID 1148286.
  55. ^ Maher TJ, Glaeser BS, Wurtman RJ (1984). "Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake". Am. J. Clin. Nutr. 39 (5): 722–9. PMID 6538743.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  56. ^ Intrinsic Fluorescence of Proteins and Peptides
  57. ^ Vivian JT, Callis PR (2001). "Mechanisms of tryptophan fluorescence shifts in proteins". Biophys. J. 80 (5): 2093–109. PMID 11325713.

External links